Patient-reported and physician-estimated adherence to HAART

AbstractOBJECTIVES: To evaluate the rate of discordance between patients and physicians on adherence to highly active antiretroviral therapy (HAART) and identify factors related to discordance in these two assessments. DESIGN: Prospective, multicenter, cohort study (AdICONA) nested within the Italian Cohort Naïve Antiretrovirals (ICONA) study. SETTING: Tertiary clinical centers. PARTICIPANTS: The patients filled out a 16-item self-administered questionnaire on adherence to HAART. At the same time, physicians estimated the current HAART adherence of their patient. MAIN OUTCOME MEASURE: Discordance between patient and physician on adherence to antiretroviral therapy. RESULTS: From May 1999 to March 2000, 320 paired patient-physician assessments were obtained. Patients had a mean plasma HIV RNA of 315 copies/ml (64% had undetectable HIV RNA) and a mean CD4+ cell count of 577 cells × 106/L. Nonadherence was reported by 30.9% of patients and estimated by physicians in 45.0% cases. In 111 cases (34.7%), patients and physicians were discordant on adherence to HAART. Kappa statistics was 0.27. Using patient-assessed adherence as reference, sensitivity, specificity, positive predictive value, and negative predictive value of physician-estimated adherence were 64.7%, 66.6%, 81.2%, and 45.8%, respectively. On multivariable analysis, low education level, unemployment, absence of a social worker in the clinical center, and unavailability of afternoon visits were significantly correlated with patient-physician discordance on adherence to antiretrovirals. CONCLUSIONS: Physicians did not correctly estimate patient-reported adherence to HAART in more than one third of patients. Both social variables and factors related to the clinical center were important predictors of discordance between patients and physicians. Interventions to enhance adherence should include strategies addressed to improve patient-physician relationship.

[1]  D Johnson,et al.  The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. , 1999, AIDS.

[2]  N. Tubiana-Rufi,et al.  Discordance between physician and adolescent assessments of adherence to treatment: influence of HbA1c level. The PEDIAB Collaborative Group. , 1999, Diabetes Care.

[3]  A. Loundou,et al.  Physician Recognition of Active Injection Drug Use In HIV-Infected Patients Is Lower Than Validity of Patient's Self-Reported Drug Use , 2001 .

[4]  R. Haynes,et al.  Is this patient taking the treatment as prescribed , 1993 .

[5]  M. Moroni,et al.  Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients , 2000, AIDS.

[6]  Barbara Gandek,et al.  Patient and Visit Characteristics Related to Physicians' Participatory Decision-Making Style: Results from the Medical Outcomes Study , 1995, Medical care.

[7]  William A. Knaus,et al.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. , 1995, JAMA.

[8]  A. Antinori,et al.  Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) , 2002, AIDS.

[9]  D. Brody Physician recognition of behavioral, psychological, and social aspects of medical care. , 1980, Archives of internal medicine.

[10]  W. Gregory,et al.  Who should measure quality of life, the doctor or the patient? , 1988, British Journal of Cancer.

[11]  J. Fleishman,et al.  Effect of Case Management on Unmet Needs and Utilization of Medical Care and Medications among HIV-Infected Persons , 2001, Annals of Internal Medicine.

[12]  A. Wu,et al.  Patient-reported nonadherence to HAART is related to protease inhibitor levels. , 2000 .

[13]  N. Aaronson,et al.  The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review , 1992 .

[14]  Christianna S. Williams,et al.  Goals for the care of frail older adults: do caregivers and clinicians agree? , 2001, The American journal of medicine.

[15]  H. Rubin,et al.  A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection , 1991, Medical care.

[16]  J. Moatti,et al.  The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort , 2001, Journal of acquired immune deficiency syndromes.

[17]  D. Richman,et al.  Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. , 2000 .

[18]  R. Califf,et al.  Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. , 1996, Archives of internal medicine.

[19]  D. Patrick,et al.  The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians. , 1999, AIDS.

[20]  S. van der Linden,et al.  Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. , 1994, Journal of Rheumatology.

[21]  V. Calvez,et al.  Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). , 2000, JAMA.

[22]  A. Fontaine,et al.  Physicians' recognition of the symptoms experienced by HIV patients: how reliable? , 1999, Journal of pain and symptom management.

[23]  J. Moatti,et al.  Injecting drug users' adherence to HIV antiretroviral treatments: Physicians' beliefs , 2000, AIDS care.

[24]  R. Epstein,et al.  Awkward Moments in Patient-Physician Communication about HIV Risk , 1998, Annals of Internal Medicine.

[25]  Marilyn M. Wagener,et al.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000) , 2002 .

[26]  E. Kohli,et al.  Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  P. Viens,et al.  Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. , 1997, British Journal of Cancer.

[28]  E. H. Kaplan,et al.  Public Health Consequences of Screening Patients for Adherence to Highly Active Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[29]  F. Brun-Vézinet,et al.  Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen , 2002, AIDS.

[30]  F. Hecht,et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.

[31]  W. Söllner,et al.  How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? , 2001, British Journal of Cancer.

[32]  R B Haynes,et al.  Predicting compliance with a regimen of digoxin therapy in family practice. , 1980, Canadian Medical Association journal.

[33]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[34]  A. Wu,et al.  Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. , 1999, Journal of acquired immune deficiency syndromes.

[35]  A. Wu,et al.  Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[36]  M. Wainberg,et al.  Public health implications of antiretroviral therapy and HIV drug resistance. , 1998, JAMA.

[37]  D. Nicolau,et al.  Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  F. Hecht,et al.  Provider Assessment of Adherence to HIV Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.